Published in World J Gastroenterol on July 14, 2011
Metastatic hepatocellular carcinoma in a patient with Crohn's disease treated with azathioprine and infliximab: a case report and literature review. Case Rep Gastrointest Med (2014) 0.82
Recurrent Hepatocellular Carcinoma in Patient with Crohn's Disease: Incidental or Expected Outcome of Azathioprine? Case Rep Gastrointest Med (2015) 0.75
Emergence of diverse Helicobacter species in the pathogenesis of gastric and enterohepatic diseases. Clin Microbiol Rev (2001) 2.97
The non-H pylori helicobacters: their expanding role in gastrointestinal and systemic diseases. Gut (2002) 2.67
Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease. Lancet (1994) 2.04
The risk of cancer in patients with Crohn's disease. Dis Colon Rectum (2007) 1.80
Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens. Gut (2010) 1.47
Long-term risk of malignancy after treatment of inflammatory bowel disease with azathioprine. Aliment Pharmacol Ther (2002) 1.41
Meta-analysis of risk of malignancy with immunosuppressive drugs in inflammatory bowel disease. Ann Pharmacother (2007) 1.10
Are we giving azathioprine too late? The case for early immunomodulation in inflammatory bowel disease. World J Gastroenterol (2008) 0.96
Hepatocellular carcinoma occurring in a Crohn's disease patient. World J Gastroenterol (2010) 0.91
DNA of Helicobacter spp. and common gut bacteria in primary liver carcinoma. Dig Liver Dis (2007) 0.90
Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med (2004) 12.20
Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study. Gastroenterology (2013) 3.55
The Asia-Pacific consensus on ulcerative colitis. J Gastroenterol Hepatol (2010) 1.93
World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010. Inflamm Bowel Dis (2010) 1.82
Cutting edge: Increased IL-17-secreting T cells in children with new-onset type 1 diabetes. J Immunol (2010) 1.40
Differentiation between intestinal tuberculosis and Crohn's disease in endoscopic biopsy specimens by polymerase chain reaction. Am J Gastroenterol (2002) 1.39
Identification and functional characterization of 2 variant alleles of the telomerase RNA template gene (TERC) in a patient with dyskeratosis congenita. Blood (2005) 1.37
Is human immunosenescence clinically relevant? Looking for 'immunological risk phenotypes'. Trends Immunol (2002) 1.24
Identification of Novel HLA-A*0201-restricted epitopes in recent-onset type 1 diabetic subjects and antibody-positive relatives. Diabetes (2006) 1.21
Clinical manifestations of inflammatory bowel disease: East and West differences. J Dig Dis (2007) 1.17
The London position statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: safety. Am J Gastroenterol (2011) 1.15
Clinical value of fecal calprotectin in determining disease activity of ulcerative colitis. World J Gastroenterol (2008) 1.14
Probiotics inhibit TNF-alpha-induced interleukin-8 secretion of HT29 cells. World J Gastroenterol (2004) 1.03
Ulcerative colitis in China: retrospective analysis of 3100 hospitalized patients. J Gastroenterol Hepatol (2007) 0.99
Classification of tea category using a portable electronic nose based on an odor imaging sensor array. J Pharm Biomed Anal (2013) 0.99
Identification and characterization of novel cell wall hydrolase CwlT: a two-domain autolysin exhibiting n-acetylmuramidase and DL-endopeptidase activities. J Biol Chem (2008) 0.98
Progression of inflammatory bowel disease in China. J Dig Dis (2010) 0.98
Consensus on the management of inflammatory bowel disease in China in 2007. J Dig Dis (2008) 0.95
New cross-bridged cyclam derivative CB-TE1K1P, an improved bifunctional chelator for copper radionuclides. Chem Commun (Camb) (2014) 0.91
Simultaneous determination of amino acid nitrogen and total acid in soy sauce using near infrared spectroscopy combined with characteristic variables selection. Food Sci Technol Int (2013) 0.90
Automated tea quality classification by hyperspectral imaging. Appl Opt (2009) 0.90
Primary intestinal NK/T cell lymphoma: a clinicopathologic study of 25 Chinese cases. Arch Iran Med (2012) 0.89
Tetrandrine attenuates spatial memory impairment and hippocampal neuroinflammation via inhibiting NF-κB activation in a rat model of Alzheimer's disease induced by amyloid-β(1-42). Brain Res (2011) 0.89
NF-kappaB p65 antisense oligonucleotides may serve as a novel molecular approach for the treatment of patients with ulcerative colitis. Arch Med Res (2008) 0.89
Basic biology and clinical impact of immunosenescence. Exp Gerontol (2002) 0.88
Expansion of peripheral CD8+ CD28- T cells in response to Epstein-Barr virus in patients with rheumatoid arthritis. J Rheumatol (2005) 0.87
Sulfasalazine inhibits activation of nuclear factor-kappaB in patients with ulcerative colitis. J Gastroenterol Hepatol (2005) 0.87
Significance of antineutrophil cytoplasmic antibody in adult patients with Henoch-Schönlein purpura presenting mainly with gastrointestinal symptoms. World J Gastroenterol (2008) 0.85
A case of rapid growing colonic NK/T cell lymphoma complicated by Crohn's disease. Chin J Cancer Res (2013) 0.85
Purple canola: Arabidopsis PAP1 increases antioxidants and phenolics in Brassica napus leaves. J Agric Food Chem (2010) 0.84
64Cu-labeled somatostatin analogues conjugated with cross-bridged phosphonate-based chelators via strain-promoted click chemistry for PET imaging: in silico through in vivo studies. J Med Chem (2014) 0.84
A clinical trial of combined use of rosiglitazone and 5-aminosalicylate for ulcerative colitis. World J Gastroenterol (2008) 0.83
Comparisons of different regressions tools in measurement of antioxidant activity in green tea using near infrared spectroscopy. J Pharm Biomed Anal (2011) 0.83
[Expression and significance of mucosal beta-defensin-2, TNFalpha and IL-1beta in ulcerative colitis]. Zhonghua Nei Ke Za Zhi (2008) 0.82
Features of intestinal T-cell lymphomas in Chinese population without evidence of celiac disease and their close association with Epstein-Barr virus infection. Chin Med J (Engl) (2005) 0.82
Novel triaryl sulfonamide derivatives as selective cannabinoid receptor 2 inverse agonists and osteoclast inhibitors: discovery, optimization, and biological evaluation. J Med Chem (2013) 0.82
An experimental study of extracellular signal-regulated kinase and its interventional treatments in hepatic fibrosis. Hepatobiliary Pancreat Dis Int (2008) 0.81
[A comparison of clinical and pathologic characteristics between Crohn's disease and intestinal tuberculosis]. Zhonghua Nei Ke Za Zhi (2009) 0.81
[Significance of fecal lactoferrin in evaluation of disease activity in ulcerative colitis]. Zhonghua Yi Xue Za Zhi (2007) 0.80
Crohn's disease and primary sclerosing cholangitis: a case report and review of the literature. Intern Med (2012) 0.80
[Activation of nuclear factor-kappaB and effects of anti-inflammatory treatment thereon in intestinal mucosa of patients with ulcerative colitis]. Zhonghua Yi Xue Za Zhi (2002) 0.80
[Effects of Bawei Xilei San on mice with oxazolone-induced colitis and the mechanisms]. Zhong Xi Yi Jie He Xue Bao (2010) 0.80
Cronkhite-Canada syndrome: a case report and review of literature. J Dig Dis (2013) 0.79
[The effects of anti-inflammatory on activation of nuclear factor-kappaB and expression of cell adhesion molecules in patients with ulcerative colitis]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi (2004) 0.79
[A clinical trial of rosiglitazone and 5-aminosalicylate combination for ulcerative colitis]. Zhonghua Nei Ke Za Zhi (2006) 0.79
Diallyl trisulfide inhibits tumor necrosis factor-alpha expression in inflammed mucosa of ulcerative colitis. Dig Dis Sci (2005) 0.78
[Expression with TGFbeta1 in the patients with ulcerative colitis]. Sichuan Da Xue Xue Bao Yi Xue Ban (2005) 0.78
Significance of glucocorticoid receptor expression in colonic mucosal cells of patients with ulcerative colitis. World J Gastroenterol (2005) 0.78
Oxazolone-induced murine model of ulcerative colitis. Chin J Dig Dis (2004) 0.78
Pathways to a robust immune response in the elderly. Immunol Allergy Clin North Am (2003) 0.78
The abl/bcr gene product as a novel leukemia-specific antigen: peptides spanning the fusion region of abl/bcr can be recognized by both CD4+ and CD8+ T lymphocytes. Cancer Immunol Immunother (2003) 0.78
Combined histology and molecular biology for diagnosis of early stage gastric MALT lymphoma. Chin J Dig Dis (2006) 0.78
[Interleukin 18 expression in colon cancer and adenoma]. Sichuan Da Xue Xue Bao Yi Xue Ban (2003) 0.78
[A retrospective analysis of azathioprine in the treatment of 24 patients with refractory ulcerative colitis]. Zhonghua Nei Ke Za Zhi (2012) 0.77
[Activation of nuclear factor-kappaB and its relationship with cytokine gene expression in colonic mucosa of ulcerative colitis patients]. Zhonghua Nei Ke Za Zhi (2002) 0.77
[The growth inhibition of colorectal adenoma cells by sulindac and its mechanisms]. Hua Xi Yi Ke Da Xue Xue Bao (2002) 0.77
[Analysis of surgical treatment for severe ulcerative colitis]. Zhonghua Wei Chang Wai Ke Za Zhi (2010) 0.77
Development of an MHC-class I peptide selection assay combining nanoparticle technology and matrix-assisted laser desorption/ionisation mass spectrometry. J Immunol Methods (2003) 0.77
[Standardized diagnosis and treatment for inflammatory bowel disease]. Zhonghua Nei Ke Za Zhi (2008) 0.76
Basic biology and clinical impact of immunosenescence. Biogerontology (2004) 0.76
Basic research on inflammatory bowel disease in China. J Dig Dis (2007) 0.76
Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel disease. Cochrane Database Syst Rev (2014) 0.76
[Expression of phosphatidylinositol 3-kinase and effects of wortmannin on the expression of tumor necrosis factor-alpha in ulcerative colitis]. Zhonghua Yi Xue Za Zhi (2007) 0.76
[Primary intestinal non-Hodgkin's lymphoma: a retrospective study of 85 cases]. Nan Fang Yi Ke Da Xue Xue Bao (2012) 0.76
Palliative care intervention in the intensive care unit: comparing outcomes among seriously ill Asian patients and those of other ethnicities. J Palliat Care (2014) 0.76
Targeting cyclooxygenase-2 with sodium butyrate and NSAIDs on colorectal adenoma/carcinoma cells. World J Gastroenterol (2004) 0.76
Sustained efficacy of adefovir add-on therapy in chronic hepatitis B patient with a poor virological response to peginterferon alfa. Scand J Gastroenterol (2012) 0.76
World Gastroenterology Organisation Global Guidelines Inflammatory Bowel Disease: Update August 2015. J Clin Gastroenterol (2016) 0.76
Recent advances in antimultiple myeloma drug development. Pharm Pat Anal (2014) 0.75
Diagnostic criteria of inflammatory bowel disease. Clin Immunol (2011) 0.75
Modeling skin sensitization potential of mechanistically hard-to-be-classified aniline and phenol compounds with quantum mechanistic properties. BMC Pharmacol Toxicol (2014) 0.75
Early aggressive therapy for severe extensive ulcerative colitis. World J Gastroenterol (2009) 0.75
[The primary culture methods of colorectal adenoma cells]. Hua Xi Yi Ke Da Xue Xue Bao (2002) 0.75
[Activation of nuclear factor-kappa B and expression of cytokine in intestinal epithelia stimulated by TNF-alpha]. Sichuan Da Xue Xue Bao Yi Xue Ban (2004) 0.75
Different roles for p16(INK) (4a) -Rb pathway and INK4a/ARF methylation between adenocarcinomas of gastric cardia and distal stomach. J Gastroenterol Hepatol (2014) 0.75
[Induction of NAG-1 gene expression in colon cancer cells by non-steroidal anti-inflammatory drugs]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi (2007) 0.75
[The effects of p38 mitogen activated protein kinase inhibitor SB203580 on colonic mucosa tumor necrosis factor alpha expression in ulcerative colitis]. Zhonghua Nei Ke Za Zhi (2007) 0.75
[The preventive and therapeutic effects of low molecular weight heparin on DSS-induced colitis in mice]. Sichuan Da Xue Xue Bao Yi Xue Ban (2003) 0.75
[The clinical, pathological features and expression of Ki-67 and COX-2 in severe reflux esophagitis and Barrett's esophagus]. Sichuan Da Xue Xue Bao Yi Xue Ban (2005) 0.75
Immunosenescence in Montecatini. Biogerontology (2003) 0.75
[The effects of nuclear factor-kappa B p65 antisense oligonucleotides on expression of proinflammatory cytokines in lamina propria mononuclear cells from patients with ulcerative colitis]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi (2003) 0.75
[The effects of butyrates and non-steroidal anti-inflammatory agents on HT-29 colonic carcinoma cells]. Zhonghua Nei Ke Za Zhi (2002) 0.75
Substrate-controlled switchable asymmetric annulations to access polyheterocyclic skeletons. Chem Commun (Camb) (2016) 0.75
[Investigation of the effect of Na-butyrate on TNBS induced rat colitis]. Sichuan Da Xue Xue Bao Yi Xue Ban (2003) 0.75
[Effects of selective and non-selective cyclooxygenase-2 inhibitor on the growth of colon cancer cells]. Sichuan Da Xue Xue Bao Yi Xue Ban (2006) 0.75
[Study the effect and mechanism of thalidomide in model of inflammatory bowed disease]. Sichuan Da Xue Xue Bao Yi Xue Ban (2005) 0.75
[The role of COX-2 in the regulation of Wnt signal pathway]. Zhonghua Nei Ke Za Zhi (2010) 0.75
[Measurement of chlorophyll content and distribution in tea plant's leaf using hyperspectral imaging technique]. Guang Pu Xue Yu Guang Pu Fen Xi (2011) 0.75
[The expression of API2-MALT1 fusion gene and its influence on the cellular apoptosis and proliferation in gastrointestinal MALT lymphoma]. Sichuan Da Xue Xue Bao Yi Xue Ban (2004) 0.75
The microvascular thrombi of colonic tissue in ulcerative colitis. Dig Dis Sci (2007) 0.75
[The early diagnosis and treatment of gastric mucosa-associated lymphoma]. Zhonghua Nei Ke Za Zhi (2003) 0.75
[Expression and clinical significance of TLR4 and NF-κB in cholesterol pneumonia]. Zhonghua Bing Li Xue Za Zhi (2015) 0.75
Bacterial immune interaction in experimental colitis. J Dig Dis (2013) 0.75
[Study on the ReHo in treatment-naïve of temporal lobe epilepsy patients with depressive symptoms using resting functional-MRI (fMRI)]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi (2012) 0.75
[Effects of NaBT and NSAIDs on colorectal adenoma-carcinoma cells]. Sichuan Da Xue Xue Bao Yi Xue Ban (2003) 0.75
[Study on glucocorticoid receptor alpha and beta in colonic mucosal cell of patients with ulcerative colitis]. Sichuan Da Xue Xue Bao Yi Xue Ban (2004) 0.75
Development of an Inner Filter Effects-based Upconversion Nanoparticles-Curcumin Nanosystem for the Sensitive Sensing of Fluoride Ion. ACS Appl Mater Interfaces (2017) 0.75
Rhodium-catalysed direct C-H allylation of N-sulfonyl ketimines with allyl carbonates. Chem Commun (Camb) (2015) 0.75
[Focal nonspecific ileocecum inflammation: a follow-up study of 66 cases]. Nan Fang Yi Ke Da Xue Xue Bao (2016) 0.75
[Study on the molecular expression and regulation of toll pathway in HT-29 cells]. Sichuan Da Xue Xue Bao Yi Xue Ban (2010) 0.75